Identification of SARS-CoV-2 inhibitors from extracts of Houttuynia cordata Thunb.

Houttuynia cordata Thunb., a perennial herb belonging to the Saururaceae family is a well-known ingredient of Traditional Chinese medicine (TCM) with several therapeutic properties. During the severe acute respiratory syndrome (SARS) outbreak in China, it was one of the approved ingredients in SARS...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Arun Bahadur Gurung, Mohammad Ajmal Ali, Joongku Lee, Mohammad Abul Farah, Khalid Mashay Al-Anazi, Fahad Al-Hemaid
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/665c9cebb99f40a990cb391db9874390
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:665c9cebb99f40a990cb391db9874390
record_format dspace
spelling oai:doaj.org-article:665c9cebb99f40a990cb391db98743902021-11-20T04:57:17ZIdentification of SARS-CoV-2 inhibitors from extracts of Houttuynia cordata Thunb.1319-562X10.1016/j.sjbs.2021.08.100https://doaj.org/article/665c9cebb99f40a990cb391db98743902021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1319562X21007889https://doaj.org/toc/1319-562XHouttuynia cordata Thunb., a perennial herb belonging to the Saururaceae family is a well-known ingredient of Traditional Chinese medicine (TCM) with several therapeutic properties. During the severe acute respiratory syndrome (SARS) outbreak in China, it was one of the approved ingredients in SARS preventative formulations and therefore, the plant may contain novel bioactive chemicals that can be used to suppress the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus for which there are currently no effective drugs available. Like all RNA viruses, SARS-CoV-2 encode RNA-dependent RNA polymerase (RdRp) enzyme which aids viral gene transcription and replication. The present study is aimed at understanding the potential of bioactive compounds from H. cordata as inhibitors of the SARS-CoV-2 RdRp enzyme. We investigated the drug-likeness of the plant's active constituents, such as alkaloids, polyphenols, and flavonoids, as well as their binding affinity for the RdRp enzyme. Molecular docking experiments show that compounds 3 (1,2,3,4,5-pentamethoxy-dibenzo-quinolin-7-one), 14 (7-oxodehydroasimilobine), and 21 (1,2-dimethoxy-3-hydroxy-5-oxonoraporphine) have a high affinity for the drug target and that the complexes are maintained by hydrogen bonds with residues like Arg553, Cys622 and Asp623, as well as hydrophobic interactions with other residues. The lead compounds' complexes with the target enzyme remained stable throughout the molecular dynamics simulation. Analysis of molecular mechanics Poisson–Boltzmann surface area (MM-PBSA) and molecular mechanics generalized Born surface area (MM-GBSA) revealed the key residues contributing considerably to binding free energy. Thus, the findings reveal the potential of H. cordata bioactive compounds as anti-SARS-CoV-2 drug candidate molecules against the target enzyme.Arun Bahadur GurungMohammad Ajmal AliJoongku LeeMohammad Abul FarahKhalid Mashay Al-AnaziFahad Al-HemaidElsevierarticleCoronavirusesCoronaviral RdRpHouttuynia cordataBioactive compoundsNatural productsCOVID-19Biology (General)QH301-705.5ENSaudi Journal of Biological Sciences, Vol 28, Iss 12, Pp 7517-7527 (2021)
institution DOAJ
collection DOAJ
language EN
topic Coronaviruses
Coronaviral RdRp
Houttuynia cordata
Bioactive compounds
Natural products
COVID-19
Biology (General)
QH301-705.5
spellingShingle Coronaviruses
Coronaviral RdRp
Houttuynia cordata
Bioactive compounds
Natural products
COVID-19
Biology (General)
QH301-705.5
Arun Bahadur Gurung
Mohammad Ajmal Ali
Joongku Lee
Mohammad Abul Farah
Khalid Mashay Al-Anazi
Fahad Al-Hemaid
Identification of SARS-CoV-2 inhibitors from extracts of Houttuynia cordata Thunb.
description Houttuynia cordata Thunb., a perennial herb belonging to the Saururaceae family is a well-known ingredient of Traditional Chinese medicine (TCM) with several therapeutic properties. During the severe acute respiratory syndrome (SARS) outbreak in China, it was one of the approved ingredients in SARS preventative formulations and therefore, the plant may contain novel bioactive chemicals that can be used to suppress the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus for which there are currently no effective drugs available. Like all RNA viruses, SARS-CoV-2 encode RNA-dependent RNA polymerase (RdRp) enzyme which aids viral gene transcription and replication. The present study is aimed at understanding the potential of bioactive compounds from H. cordata as inhibitors of the SARS-CoV-2 RdRp enzyme. We investigated the drug-likeness of the plant's active constituents, such as alkaloids, polyphenols, and flavonoids, as well as their binding affinity for the RdRp enzyme. Molecular docking experiments show that compounds 3 (1,2,3,4,5-pentamethoxy-dibenzo-quinolin-7-one), 14 (7-oxodehydroasimilobine), and 21 (1,2-dimethoxy-3-hydroxy-5-oxonoraporphine) have a high affinity for the drug target and that the complexes are maintained by hydrogen bonds with residues like Arg553, Cys622 and Asp623, as well as hydrophobic interactions with other residues. The lead compounds' complexes with the target enzyme remained stable throughout the molecular dynamics simulation. Analysis of molecular mechanics Poisson–Boltzmann surface area (MM-PBSA) and molecular mechanics generalized Born surface area (MM-GBSA) revealed the key residues contributing considerably to binding free energy. Thus, the findings reveal the potential of H. cordata bioactive compounds as anti-SARS-CoV-2 drug candidate molecules against the target enzyme.
format article
author Arun Bahadur Gurung
Mohammad Ajmal Ali
Joongku Lee
Mohammad Abul Farah
Khalid Mashay Al-Anazi
Fahad Al-Hemaid
author_facet Arun Bahadur Gurung
Mohammad Ajmal Ali
Joongku Lee
Mohammad Abul Farah
Khalid Mashay Al-Anazi
Fahad Al-Hemaid
author_sort Arun Bahadur Gurung
title Identification of SARS-CoV-2 inhibitors from extracts of Houttuynia cordata Thunb.
title_short Identification of SARS-CoV-2 inhibitors from extracts of Houttuynia cordata Thunb.
title_full Identification of SARS-CoV-2 inhibitors from extracts of Houttuynia cordata Thunb.
title_fullStr Identification of SARS-CoV-2 inhibitors from extracts of Houttuynia cordata Thunb.
title_full_unstemmed Identification of SARS-CoV-2 inhibitors from extracts of Houttuynia cordata Thunb.
title_sort identification of sars-cov-2 inhibitors from extracts of houttuynia cordata thunb.
publisher Elsevier
publishDate 2021
url https://doaj.org/article/665c9cebb99f40a990cb391db9874390
work_keys_str_mv AT arunbahadurgurung identificationofsarscov2inhibitorsfromextractsofhouttuyniacordatathunb
AT mohammadajmalali identificationofsarscov2inhibitorsfromextractsofhouttuyniacordatathunb
AT joongkulee identificationofsarscov2inhibitorsfromextractsofhouttuyniacordatathunb
AT mohammadabulfarah identificationofsarscov2inhibitorsfromextractsofhouttuyniacordatathunb
AT khalidmashayalanazi identificationofsarscov2inhibitorsfromextractsofhouttuyniacordatathunb
AT fahadalhemaid identificationofsarscov2inhibitorsfromextractsofhouttuyniacordatathunb
_version_ 1718419718305480704